Article
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
22 May 2019
Abstract excerpt
Tumor immunology has changed the landscape of cancer treatment. Yet, not all patients benefit as cancer immune responsiveness (CIR) remains a limitation in a considerable proportion of cases. The multifactorial determinants of CIR include the genetic makeup of the patient, the genomic instability central to cancer development, the evolutionary emergence of cancer phenotypes under the influence of immune editing,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
